Overview

Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
People with type 2 diabetes experience heart failure more often than do people without diabetes. This may be due to increased stiffness in the heart as a result of diabetes. This study will examine whether exenatide, a medication used to treat diabetes, may have beneficial effects on the heart in people with type 2 diabetes and heart failure.
Phase:
Phase 4
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Exenatide
Glucagon-Like Peptide 1